Characterization of Macrophage Galactose-type Lectin (MGL) ligands in colorectal cancer cell lines-Reference-Cited by-同舟云学术

Characterization of Macrophage Galactose-type Lectin (MGL) ligands in colorectal cancer cell lines

Published:2020-04 Issue:4 Volume:1864 Page:129513
ISSN:0304-4165
Container-title:Biochimica et Biophysica Acta (BBA) - General Subjects
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - General Subjects

Author:

Pirro Martina,Rombouts Yoann,Stella Alexandre,Neyrolles Olivier,Burlet-Schiltz Odile,van Vliet Sandra J.,de Ru Arnoud H.,Mohammed Yassene,Wuhrer Manfred,van Veelen Peter A.,Hensbergen Paul J.

Funder

European Commissions Horizon 2020

Investment Grant NWO Medium

Région Occitanie and the French Ministry of Research

Proteomics French Infrastructure

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference44 articles.

1. Glycosylation in cancer: mechanisms and clinical implications;Pinho;Nat. Rev. Cancer,2015

2. Glycosylation characteristics of colorectal cancer;Holst;Adv. Cancer Res.,2015

3. Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers;Ju;Proteome. Clin. Appl.,2013

4. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen;Fu;HLA,2016

5. Terminal N-acetylgalactosamine-specific leguminous lectin from Wisteria japonica as a probe for human lung squamous cell carcinoma;Soga;PLoS One,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epstein-Barr virus nuclear antigen EBNA3A modulates IRF3-dependent IFNβ expression;Journal of Biological Chemistry;2024-09

2. The pleiotropic CLEC10A: implications for harnessing this receptor in the tumor microenvironment;Expert Opinion on Therapeutic Targets;2024-07-02

3. Glycan Profiling in Small Extracellular Vesicles with a SERS Microfluidic Biosensor Identifies Early Malignant Development in Lung Cancer;Advanced Science;2024-06-17

4. Ligand Recognition by the Macrophage Galactose-Type C-Type Lectin: Self or Non-Self?—A Way to Trick the Host’s Immune System;International Journal of Molecular Sciences;2023-12-03

5. Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors;Cancers;2023-07-08